Durakinase Injection
- Company Name:DongKook Pharm. Co., Ltd.
- Membership:Free Member
- Member Since:2003. 02.14
- Country/Region:Korea
- City:Chungcheongbuk-do
- Contact:Jisung Yun
- Related Keywords:Durakinase Injection
Contact us
DongKook Pharm. Co., Ltd.
[Korea]
Description
Durakinase Injection has the outstanding thrombolytic effects in acute evolving
transmural myocardial infarction, acute massive pulmonary embolism, acute deep
vein thrombosis, acute arterial thrombosis and embolism, occluded arteriovenous
cannulae.
Ingredients
1 vial contains Streptokinase(B.P.) 750,000IU/1,500,000IU.
Indications
Acute myocardial infarction, acute deep vein thrombosis,
acute pulmonary embolism, acute arterial occlusion,
conglobation of arteriovenous shunt
Dosage and Administration
For further information, please see the insert.
Shelf life
2 years
Storage
Store at room temperature, in a hermetic container
protected from light.
How supplied
750,000 IU : 1 vial/Box
1,500,000 IU : 1 vial/Box
Other products from this supplier
Browse: Manufacturer Directory Countries China India Korea Premium Suppliers Community Site Map
About EC21 Contact Us Terms & Conditions Report Item Online Trading Risks Product Listing Policy
中文 繁體 한국어 日本語 Español Русский Français Deutsch
Copyright (c)1997-2024 EC21 Inc. All Rights Reserved. EC21 in KoreanChinese
Business Registry Number: 120-86-03931